A clinical assessment of the use of etomidate in children

Area of Science:

• Anesthesiology
• Pediatric Anesthesia

Background:

• Etomidate is an anesthetic agent used for induction of anesthesia.
• Its use in pediatric populations requires careful consideration of safety and efficacy.

Purpose of the Study:

• To evaluate the efficacy and safety of etomidate for inducing sleep in pediatric patients.
• To identify common adverse events and assess clinical acceptability.

Main Methods:

• A study involving 198 children who received intravenous etomidate at a dose of 0.2 mg/kg for sleep induction.
• Monitoring of cardiovascular and respiratory systems, and recording of adverse events such as pain and myoclonia.

Main Results:

• Etomidate rapidly induced sleep with minimal cardiovascular and respiratory impact.
• Common adverse events included injection site pain (27%), myoclonia (10%), and inadequate dosage (19%).

Conclusions:

• Etomidate is a safe and rapid hypnotic agent for children, but its clinical utility is limited by injection pain and myoclonia.
• Strategies to mitigate these issues include analgesic premedication, increased etomidate dosage (0.3-0.4 mg/kg), or formulation changes.